Results 251 to 260 of about 72,862 (382)

[Properties and mechanism of hyperlipidemia induced in rabbits by tributyltin fluoride].

, 1982
Hisao Matsui, Osamu WADA, Shigeo Manabe, Tetsu ONO, Hideaki Iwai, Takashi Fujikura   +5 more
openalex   +2 more sources

Critical insights into the potential risks of antipsychotic drugs to fish, including through effects on behaviour

Biological Reviews, EarlyView.
ABSTRACT Antipsychotic drugs (APDs) are a diverse class of neuroactive pharmaceuticals increasingly detected in surface and ground waters globally. Some APDs are classified as posing a high environmental risk, due, in part, to their tendency to bioaccumulate in wildlife, including fish.
Gabrielle Wasser‐Bennett, A. Ross Brown, Samuel K. Maynard, Stewart F. Owen, Charles R. Tyler   +4 more
wiley   +1 more source

Sex differences in the association between composite dietary antioxidant index and hyperlipidemia: Insights from NHANES. [PDF]

PLoS One
Miao X, Li B, Zhu Z, Yang T.
europepmc   +1 more source

Effect of NIP-200 on hyperlipidemia and atherosclerosis in cholesterol-fed rabbits.

, 1987
Koji Sakamoto, Mayumi Yamauchi, Sadao NAKAYAMA, Nobutomo Tsuruzoe, Mitsuaki Sakashita, Yoshihiro Fujikawa   +5 more
openalex   +2 more sources

Potential Impact of Parental Origin of Inheritance on the Clinical Presentation of Familial Partial Lipodystrophy Type 2 Syndrome

Clinical Endocrinology, EarlyView.
ABSTRACT Context Familial partial lipodystrophy type 2 (FPLD2) is a rare autosomal dominant disorder caused by pathogenic variants in the LMNA gene. The influence of parental inheritance on clinical presentation has not been fully explored. Objective To investigate the influence of maternal versus paternal inheritance of LMNA variants on the clinical ...
Donatella Gilio, Ozge Besci, Natália Rossin Guidorizzi, Merve Celik Guler, Ilgin Yildirim Simsir, Caterina Pelosini, Giovanni Ceccarini, Korcan Demir, Baris Akinci, Ferruccio Santini, ECLip (European Consortium of Lipodystrophy), Maria Cristina Foss‐Freitas, Elif A. Oral   +12 more
wiley   +1 more source

Symposium on recent trend in the research of hyperlipidemia in Japan. (1). Profiles of primary hyperlipidemia in Japan.

, 1989
Yūji Matsuzawa, Seiichiro Tarui
openalex   +2 more sources

Plugging gaps in payment systems: Evidence from the take‐up of new Medicare billing codes

Contemporary Economic Policy, EarlyView.
Abstract We analyze the introduction of new Medicare billing codes for Chronic Care Management (CCM) and Transitional Care Management (TCM). We first show that new code take‐up occurs gradually and varies across space and physician characteristics. Second, we study how the codes correlate with other services, focusing on two case studies.
Jeffrey Clemens, Jonathan M. Leganza, Alex Masucci   +2 more
wiley   +1 more source

A Comparative Analysis of Low-Density Lipoprotein Cholesterol (LDL-C)-Lowering Activities of Bempedoic Acid, Inclisiran, and PCSK9 Inhibitors: A Systematic Review. [PDF]

Cureus
Rajendran Y, Nandhakumar M, Eerike M, Kondampati N, Mali K, Chalissery LF, Konda VGR, Nagireddy UM.   +7 more
europepmc   +1 more source

Effect of γ-Oryzanol on Hyperlipidemia

, 1981
Hiroshi Oimatsu, Shigeki OHTA, Toshiaki ENDO, Osamu Iimura   +3 more
openalex   +2 more sources

Decreases in circulating ANGPTL3/8 concentrations following retatrutide treatment parallel reductions in serum lipids

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims The aim of this study was to determine if retatrutide, a triple agonist of glucose‐dependent insulinotropic polypeptide (GIP) receptor, glucagon‐like peptide 1 (GLP‐1) receptor and glucagon (GCG) receptor, may lower serum triglyceride (TG) and low‐density lipoprotein cholesterol (LDL‐C) levels in part by decreasing circulating ...
Yi Wen, Deven Lemen, Yanzhu Lin, Yan Q. Chen, Ajit Regmi, William C. Roell, Melissa K. Thomas, Mark L. Hartman, Tamer Coskun, Zvonko Milicevic, Axel Haupt, Giacomo Ruotolo, Robert J. Konrad   +12 more
wiley   +1 more source